Search Results

Displaying Results 2726-2750 of 10866 "'T'"

Jun 13, 2026, 11:45 ET TTW Announces Top 50 Amusement Park Travel Destinations in the World for 2026

festivals, extended park hours, and water attractions.Top 10 Amusement Parks1. Everland, Yongin, Gyeonggi ProvinceHome to T Express, Zootopia, Safari World, themed lands, and seasonal festivals.How to Reach There: Fly into Incheon International Airport and continue

More news about: Travel And Tour World


Jun 13, 2026, 11:40 ET MGI Tech Showcases Expanding Genomics Ecosystem at ESHG 2026 with New IVD Partnering Program and OEM Collaborations

research.Highlighting strong market adoption, MGI is showcasing the T7+, its ultra-high-throughput sequencing platform at the conference. Following its official launch for the Europe and Africa region at Analytica 2026 in Munich, the T7+ has gained significant momentum, with 27 units installed worldwide

More news about: MGI Tech Co., Ltd.


Jun 13, 2026, 06:33 ET New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma

more than 11,000 patients have been treated with TALVEY ®.TALVEY® is a bispecific T-cell engaging antibody that binds to the CD3 receptor expressed on the surface of T-cells and G protein-coupled receptor class C group 5 member D (GPRC5D), a novel multiple myeloma target which

More news about: Johnson & Johnson


Jun 12, 2026, 20:49 ET Breakthrough T1D Celebrates Approval of Tzield for use in Stage 3 Type 1 Diabetes in the US

/PRNewswire/ -- Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, applauds today's decision from the U.S. Food and Drug Administration (FDA) to approve Tzield for use in individuals ages 8-17 within eight weeks of a stage 3 T1D diagnosis. Stage 3 T1D occurs when the

More news about: Breakthrough T1D, Formerly JDRF


Jun 12, 2026, 20:10 ET Deratany Law Firm y Nolan Law Group obtienen un veredicto de $ 9.1 millones por negligencia médica

Illinois).Los Demandantes alegaron que un retraso de 24 horas en el diagnóstico de una rara lesión intramedular de la médula espinal en el nivel T9 de la columna vertebral del Sr. Pleasant resultó en una oportunidad perdida para el tratamiento oportuno. Aunque la descompresión quirúrgica se realizó

More news about: Nolan Law Group


Jun 12, 2026, 16:17 ET M3-Brigade Acquisition V Corp. Announces Cancellation of Extraordinary General Meeting of Shareholders to Approve Business Combination

material.ContactsM3-Brigade Acquisition V Corp.c/o M3 Partners, LP1700 Broadway19th FloorNew York, NY 10019T: 212-202-2200

More news about: M3-Brigade Acquisition V Corp.


Jun 12, 2026, 13:41 ET Hisense celebra el inicio de la Copa Mundial de la FIFA 2026™ con la innovadora tecnología RGB MiniLED

soluciones informáticas inteligentes. Según Omdia, Hisense ocupa el primer puesto a nivel mundial en el segmento de televisores de 100 pulgadas o más (2023-2026T1). Como pionera de RGB MiniLED, Hisense continúa liderando la innovación de la próxima generación de RGB MiniLED. Como patrocinador oficial de la

More news about: Hisense


Jun 12, 2026, 13:23 ET Hisense célèbre le coup d'envoi de la Coupe du monde de la FIFA 2026™ avec une innovation en matière de RGB MiniLED

solutions informatiques intelligentes de qualité. Selon Omdia, Hisense se classe au 1er rang mondial dans le segment des téléviseurs de 100 pouces et plus (2023-T1 2026). À l'origine de la technologie RGB MiniLED, Hisense continue de mener l'innovation de nouvelle génération en matière de RGB MiniLED. En tant

More news about: Hisense


Jun 12, 2026, 13:19 ET Deratany Law Firm and Nolan Law Group Secure $9.1 Million Medical Malpractice Verdict

Plaintiffs alleged that a 24-hour delay in diagnosing a rare intramedullary spinal cord lesion at the T9 level of Mr. Pleasant's spine resulted in a missed opportunity for timely treatment. Although surgical decompression was ultimately performed after the

More news about: Nolan Law Group


Jun 12, 2026, 11:44 ET /C O R R E C T I O N -- Sazerac/

More news about: Sazerac


Jun 12, 2026, 10:35 ET /C O R R E C T I O N -- LEOTEK/

More news about: LEOTEK


Jun 12, 2026, 10:23 ET Folger Shakespeare Library Announces Aaron T. Pratt as Andrew W. Mellon Curator of Rare Books and Prints

offer meaningful research opportunities.Pratt will start in his role in August 2026.Aaron T. Pratt, Incoming Andrew W. Mellon Curator of Rare Books and PrintsAaron T. Pratt has served as Carl and Lily Pforzheimer Curator of Early Books and Manuscripts at the Harry Ransom Center

More news about: Folger Shakespeare Library


Jun 12, 2026, 10:20 ET The Metal You've Never Heard Of Is Becoming a National-Security Priority -- and America Barely Mines It

headline interval of 1.93 grams per tonne gold-equivalent over 100.6 metres from surface at its Resurrection Ridge area, and a separate hole grading 4.91 g/t gold-equivalent over 27.4 metres — and metallurgical testwork indicating that antimony and gold can be sequentially recovered from the same feed stream,

More news about: American News Group


Jun 12, 2026, 10:19 ET SK Tools Launches 2026 Father's Day Gift Guide: Dad Gifts for Every Budget

down for generations."SK Tools Father's Day GiftsGift Ideas Up to $50Crew Neck Loose Fit T-Shirts – $11.89

More news about: GreatStar Industrial USA, LLC


Jun 12, 2026, 10:00 ET ChatSee.ai Raises $6.5M led by True Ventures to Tackle the Growing Problem of AI Agent Failures

most significant AI risks emerge at runtime as agents operate autonomously," said Dr. Eduard Amoroso, CEO of TAG-infosphere (and former CISO of AT&T). "Because these systems are probabilistic and adaptive, static testing alone is insufficient. This is driving the need for continuous runtime

More news about: Chatsee AI Inc


Jun 12, 2026, 08:00 ET Silvercorp reports a Mineral Reserve increase of 50% in tonnes and 20% in silver ounces for the Ying Mining District

m.COGs: SGX 75 g/t AgEq; HZG 75 g/t AgEq; HPG 0.95 g/t AuEq; TLP 65 g/t AgEq; LME 70 g/t AgEq; LMW silver rich veins 65 g/t AgEq; LMW gold rich veins 0.85 g/t AuEq; DCG 80 g/t AgEq, KP 90 g/t AgEq.AgEq equivalent formulas by mine for silver rich veins:SGX = Ag g/t + 21.3351 *

More news about: Silvercorp Metals Inc.


Jun 12, 2026, 08:00 ET Gan & Lee Pharmaceuticals Achieves Significant Progress in Its Dual Pipeline for Metabolic Diseases -- Weekly Insulin Ludefen (GZR4) Meets Primary Endpoint in Phase III Clinical Trial in China; Bofanglutide Meets Primary Endpoints in Phase III Weight Loss Study in China and Phase II Study in the U.S.

clinical trial conducted at 80 medical sites across China (ClinicalTrials.gov Identifier: NCT06767761). The study enrolled 596 adults with type 2 diabetes (T2DM) who had previously been treated with basal-bolus insulin, premixed insulin analogs or dual insulin analog. It evaluated once-weekly Insulin Ludefen

More news about: Gan & Lee Pharmaceuticals


Jun 12, 2026, 08:00 ET Liftoff: The Day the Orbital Economy Became a Public Market

https://finance.yahoo.com/markets/stocks/articles/starfighters-space-nyse-fjet-added-100000658.html FTSE Russell / Investing.com — 2026 Russell reconstitution detail ($12.2T benchmarked; Russell 3000 up 29% to $75.6T; rank day April 30):

More news about: Baystreet


Jun 12, 2026, 07:30 ET Skylark Drones and e2E Rail Partner to Advance AI-Powered Drone Intelligence for Railway Infrastructure

infrastructure assets at scale, strengthen project execution, and improve long-term asset performance.Commenting on the partnership, Mughilan T R, CEO and Co-founder, Skylark Drones, said: "Railway infrastructure is becoming increasingly complex, making timely access to accurate intelligence

More news about: Skylark Drones


Jun 12, 2026, 03:00 ET AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results

interventions, including small molecule therapeutics, antibody-drug conjugates (ADCs), immuno-oncology-based therapeutics, multispecific antibody and novel CAR-T platforms. Our dedicated and experienced team joins forces with innovative partners to accelerate the delivery of potential breakthrough medicines.Today,

More news about: AbbVie


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.